| Non-responder | Responder | Replete | P Value‡(responder vs. non-responders) |
---|---|---|---|---|
N | 169 | 221 | 8 | Â |
Males | 86 (50.9%) | 119 (53.9%) | 6 (75.0%) | 0.56 |
Age†| 62.5 (15·5) | 64.9 (14·9) | 64.5 (18·0) | 0.12 |
Diabetes, only | 0 (0.0%) | 1 (0.45%) | 0 (0.0%) | 1.0 |
Hypertension, only | 62 (36.7%) | 97 (43.9%) | 4 (50.0%) | 0.15 |
Diabetic and hypertensive | 102 (60.4%) | 113 (51.1%) | 3 (37.5%) | 0.07 |
Non-diabetic and non-hypertensive | 5 (3.0%) | 10 (4.5%) | 1 (12.5%) | 0.43 |
CKD | 132 (78.1%) | 169 (76.5%) | 8 (100.0%) | <0.001 |
Transplant | 8 (4.7%) | 35 (15.8%) | 0 (0.0%) | |
RRT | 29 (17.2%) | 17 (7.7%) | 0 (0.0%) | |
eGFR | 30.0 (22.0) | 36·0 (27.0) |  | <0.001 |
PTH | 99.0 (137.0) | 86·5(102.0) |  | 0.08 |
Albumin | 3.9 (0.6) | 4·3 (0.4) |  | <0.001 |
Initial mean phosphate | 3.8 (1.1) | 3·5 (0.9) |  | <0.001 |
Initial mean 1,25-OH vitamin D | 20.5 (18.0) | 30.0 (19.0) | Â | <0.001 |
For CKD stages 3–5 only | ||||
Initial mean eGFR | 28·3 (11.5) | 31·5 (11.2) |  | 0.0253 |
Initial mean 25-OH vitamin D | 18·3 (9.0) | 23·6 (9.1) |  | <0.001 |